Lupin Drug Patent Portfolio

Lupin owns 5 orange book drugs protected by 38 US patents with Antara (Micronized) having the least patent protection, holding only 4 patents. And Brovana with maximum patent protection, holding 13 patents. Given below is the list of Lupin's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11684607 Secnidazole for use in the treatment of bacterial vaginosis 16 Sep, 2035
Active
US10335390 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
Active
US10682338 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
Active
US10849884 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
Active
US10857133 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
Active
US11000507 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
Active
US11000508 Secnidazole for use in the treatment of trichomoniasis 04 Sep, 2035
Active
US11020377 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
Active
US11324721 Secnidazole for use in the treatment of trichomoniasis 04 Sep, 2035
Active
US11602522 Secnidazole for use in the treatment of sexually transmitted infection 04 Sep, 2035
Active
US9314447 Reduced dose pharmaceutical compositions of fenofibrate 31 May, 2033
Active
US9493582 Alkylated cyclodextrin compositions and processes for preparing and using the same 27 Feb, 2033
Active
US7635773 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
Active
US8410077 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
Active
US9200088 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
Active
US9750822 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
Active
US8026281 Treating metabolic syndrome with fenofibrate 22 Apr, 2025
Active
US7256310 Levalbuterol salt 08 Oct, 2024
Active
US8765153 Levalbuterol salt 08 Dec, 2023 Expired
US6472563 Formoterol tartrate process and polymorph 09 Nov, 2021 Expired
US6720453 Formoterol tartrate polymorph 09 Nov, 2021 Expired
US7145036 Formoterol tartrate polymorph 09 Nov, 2021 Expired
US8110706 Formoterol tartrate process and polymorph 09 Nov, 2021 Expired
US6667344 Bronchodilating compositions and methods 22 Jun, 2021 Expired
US6814953 Bronchodilating compositions and methods 22 Jun, 2021 Expired
US7348362 Bronchodilating β-agonist compositions and methods 22 Jun, 2021 Expired
US7462645 Bronchodilating beta-agonist compositions and methods 22 Jun, 2021 Expired
US7465756 Bronchodilating beta-agonist compositions and methods 22 Jun, 2021 Expired
US7473710 Bronchodilating beta-agonist compositions and methods 22 Jun, 2021 Expired
US7541385 Bronchodilating β-agonist compositions and methods 22 Jun, 2021 Expired
US7101574 Pharmaceutical composition containing fenofibrate and the preparation method 20 Aug, 2020 Expired
US7863331 Pharmaceutical composition containing fenofibrate and method for the preparation thereof 08 Aug, 2020 Expired
US6040344 Formoterol process 12 Nov, 2016 Expired
US5836299 Seals for use in an aerosol delivery device 17 Nov, 2015 Expired
US5605674 Medicinal aerosol formulations 25 Feb, 2014 Expired
US5547994 Method for treating asthma using optically pure R(-) albuterol 20 Aug, 2013 Expired
US6589508 Methods and compositions for treating pulmonary disorders using optically pure (R,R) formoterol 03 Apr, 2013 Expired
US5362755 Method for treating asthma using optically pure (R)-albuterol 25 Mar, 2013 Expired


Given below is the list of recent legal activities going on the following drug patents of Lupin.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 17 Jul, 2024 US11000508
Payment of Maintenance Fee, 4th Year, Large Entity 17 Jul, 2024 US11000507
Expire Patent 11 Mar, 2024 US8110706
Payment of Maintenance Fee, 4th Year, Large Entity 11 Dec, 2023 US10857133
Payment of Maintenance Fee, 4th Year, Large Entity 11 Dec, 2023 US10849884
Maintenance Fee Reminder Mailed 25 Sep, 2023 US8110706
Payment of Maintenance Fee, 4th Year, Large Entity 28 Jun, 2023 US10682338
Email Notification 27 Jun, 2023 US11684607
Mail Patent eGrant Notification 27 Jun, 2023 US11684607
Recordation of Patent Grant Mailed 27 Jun, 2023 US11684607
Patent eGrant Notification 27 Jun, 2023 US11684607
Electronic Review 27 Jun, 2023 US11684607
Patent Issue Date Used in PTA Calculation 27 Jun, 2023 US11684607
Recordation of Patent eGrant 27 Jun, 2023 US11684607
Electronic Review 08 Jun, 2023 US11684607


Lupin Drug Patents' Oppositions Filed in EPO

Lupin drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Nov 16, 2011, by Teva Pharmaceutical Industries Ltd.. This opposition was filed on patent number EP06110646A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP06110646A Nov, 2011 Teva Pharmaceutical Industries Ltd. Patent maintained as amended


Lupin's Family Patents

Lupin drugs have patent protection in a total of 23 countries. It's US patent count contributes only to 32.2% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Lupin Drug List

Given below is the complete list of Lupin's drugs and the patents protecting them.


1. Antara (micronized)

Antara (micronized) is protected by 4 patents, out of which 2 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9314447 Reduced dose pharmaceutical compositions of fenofibrate 31 May, 2033
(8 years from now)
Active
US8026281 Treating metabolic syndrome with fenofibrate 22 Apr, 2025
(6 months from now)
Active
US7101574 Pharmaceutical composition containing fenofibrate and the preparation method 20 Aug, 2020
(4 years ago)
Expired
US7863331 Pharmaceutical composition containing fenofibrate and method for the preparation thereof 08 Aug, 2020
(4 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Antara (micronized)'s drug page


2. Brovana

Brovana is protected by 13 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6472563 Formoterol tartrate process and polymorph 09 Nov, 2021
(2 years ago)
Expired
US6720453 Formoterol tartrate polymorph 09 Nov, 2021
(2 years ago)
Expired
US7145036 Formoterol tartrate polymorph 09 Nov, 2021
(2 years ago)
Expired
US8110706 Formoterol tartrate process and polymorph 09 Nov, 2021
(2 years ago)
Expired
US6667344 Bronchodilating compositions and methods 22 Jun, 2021
(3 years ago)
Expired
US6814953 Bronchodilating compositions and methods 22 Jun, 2021
(3 years ago)
Expired
US7348362 Bronchodilating β-agonist compositions and methods 22 Jun, 2021
(3 years ago)
Expired
US7462645 Bronchodilating beta-agonist compositions and methods 22 Jun, 2021
(3 years ago)
Expired
US7465756 Bronchodilating beta-agonist compositions and methods 22 Jun, 2021
(3 years ago)
Expired
US7473710 Bronchodilating beta-agonist compositions and methods 22 Jun, 2021
(3 years ago)
Expired
US7541385 Bronchodilating β-agonist compositions and methods 22 Jun, 2021
(3 years ago)
Expired
US6040344 Formoterol process 12 Nov, 2016
(7 years ago)
Expired
US6589508 Methods and compositions for treating pulmonary disorders using optically pure (R,R) formoterol 03 Apr, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Brovana's drug page


3. Sesquient

Sesquient is protected by 5 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9493582 Alkylated cyclodextrin compositions and processes for preparing and using the same 27 Feb, 2033
(8 years from now)
Active
US7635773 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
(4 years from now)
Active
US8410077 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
(4 years from now)
Active
US9200088 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
(4 years from now)
Active
US9750822 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
(4 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sesquient's drug page


4. Solosec

Solosec is protected by 10 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11684607 Secnidazole for use in the treatment of bacterial vaginosis 16 Sep, 2035
(10 years from now)
Active
US10335390 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
(10 years from now)
Active
US10682338 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
(10 years from now)
Active
US10849884 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
(10 years from now)
Active
US10857133 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
(10 years from now)
Active
US11000507 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
(10 years from now)
Active
US11000508 Secnidazole for use in the treatment of trichomoniasis 04 Sep, 2035
(10 years from now)
Active
US11020377 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
(10 years from now)
Active
US11324721 Secnidazole for use in the treatment of trichomoniasis 04 Sep, 2035
(10 years from now)
Active
US11602522 Secnidazole for use in the treatment of sexually transmitted infection 04 Sep, 2035
(10 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Solosec's drug page


5. Xopenex Hfa

Xopenex Hfa is protected by 6 patents, out of which 5 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7256310 Levalbuterol salt 08 Oct, 2024
(2 days from now)
Active
US8765153 Levalbuterol salt 08 Dec, 2023
(9 months ago)
Expired
US5836299 Seals for use in an aerosol delivery device 17 Nov, 2015
(8 years ago)
Expired
US5605674 Medicinal aerosol formulations 25 Feb, 2014
(10 years ago)
Expired
US5547994 Method for treating asthma using optically pure R(-) albuterol 20 Aug, 2013
(11 years ago)
Expired
US5362755 Method for treating asthma using optically pure (R)-albuterol 25 Mar, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xopenex Hfa's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List